Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Althea Group Holdings Ltd. ( (AU:AGH) ) has shared an update.
Althea Group Holdings Ltd has revised its FY25 financial guidance, reducing expected revenue and adjusted EBITDA due to market challenges and strategic shifts, including the abandonment of a vape product initiative. Despite these adjustments, the company remains focused on enhancing operational efficiency through restructuring efforts, particularly in its pharmaceutical division, and is exploring B2B opportunities. Positive momentum continues in its North American operations, with strong performance from Peak Processing Solutions in Canada and initial success in the US market. AGH is committed to disciplined capital allocation and strategic opportunities to ensure long-term shareholder value.
More about Althea Group Holdings Ltd.
Althea Group Holdings Ltd (ASX:AGH) is a global leader specializing in the manufacturing, sales, and distribution of cannabis-based medicines and recreational cannabis products. The company operates two main business units: Peak Processing Solutions, which focuses on recreational cannabis for adult consumers, and Althea, which provides cannabis-based pharmaceutical products available by prescription. AGH is active in highly regulated cannabis markets across North America, Europe, and Australia.
YTD Price Performance: -23.33%
Average Trading Volume: 838,251
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: A$12.7M
See more insights into AGH stock on TipRanks’ Stock Analysis page.